NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

NCI-COG Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH) is a nationwide trial to explore whether targeted therapies can be effective for children and adolescents with solid tumors that harbor specific genetic mutations and have progressed during or after standard therapy.

Read more: https://www.nih.gov/news-events/news-releases/nci-cog-pediatric-match-trial-test-targeted-drugs-childhood-cancers